Pharmacogenomics Integration, Trial Outsourcing, and Real-Time Monitoring Boosting UK Clinical Trials Market Size Expansion
The UK Clinical Trials Market is expanding as pharmacogenomic-enabled drug trials increase investment in personalized medicine. Genomic testing helps determine individual drug response patterns, leading to targeted therapies and optimized dosing models. Clinical outsourcing among UK hospitals and contract research organizations (CROs) also strengthens trial execution. These operational and...
0 Comentários 0 Compartilhamentos 619 Visualizações 0 Anterior